1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Motor neurone disease

Guidance on the use of Riluzole (Rilutek) for the treatment of Motor Neurone Disease

Technology appraisal guidance [TA20] Published date: 23 January 2001

  • Guidance
  • Tools and resources
  • Information for the public
  • History

Documents

A list of downloadable documents created during development.

Other information

  • TA20 Motor neurone disease - riluzole: guidance (html) information

Background information

  • Motor neurone disease - riluzole: Static List Review Decision - April 2014 information
  • Appendix A -Static List Review paper 01 April 2014   184.51 KB
  • Riluzole for Motor Neurone Disease - HTA report part 1 22 January 2001   833.45 KB
  • Riluzole for Motor Neurone Disease - HTA report part 2 22 January 2001   31.48 KB
  • Riluzole - Appeal against guidance dated December 2000 information
  • Review of TA20 Riluzole for the treatment of motor neurone disease information
  • Review proposal 06 February 2006   36.5 KB
  • Review decision information
NICE
  • About NICE
  • Into practice
  • News
  • Contact us
  • Leave feedback
  • Jobs
  • Newsletters and alerts
  • Blog
  • Twitter
  • YouTube
  •   Facebook
  • LinkedIn

Explore

  • Guidance
  • Pathways
  • Standards and indicators
  • Evidence search
  • BNF
  • BNFC
  • Clinical knowledge summaries
  • Journals and databases

Reusing our content

  • Reuse information
  • NICE UK Open Content Licence

Get involved

  • Register as a stakeholder
  • Citizens council
  • Consultations
  • Fellows and scholars
  • Join a committee
  • Meetings in public
  • Student champions
  • Tenders
  • NICE and the public
  • Accessibility
  • Freedom of information
  • Syndication services
  • Glossary
  • Terms and conditions
  • Privacy notice

© NICE [year]. All rights reserved. Subject to Notice of rights.